MA33351B1 - Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide - Google Patents
Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramideInfo
- Publication number
- MA33351B1 MA33351B1 MA34435A MA34435A MA33351B1 MA 33351 B1 MA33351 B1 MA 33351B1 MA 34435 A MA34435 A MA 34435A MA 34435 A MA34435 A MA 34435A MA 33351 B1 MA33351 B1 MA 33351B1
- Authority
- MA
- Morocco
- Prior art keywords
- dimethyl
- morpholine
- phenyl
- stable form
- dimethylbutyramide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200900597 | 2009-05-11 | ||
PCT/DK2010/050101 WO2010130260A2 (en) | 2009-05-11 | 2010-05-11 | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33351B1 true MA33351B1 (fr) | 2012-06-01 |
Family
ID=42237259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34435A MA33351B1 (fr) | 2009-05-11 | 2010-05-11 | Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP2430008A2 (zh) |
JP (1) | JP2012526152A (zh) |
KR (1) | KR20120022934A (zh) |
CN (1) | CN102459208A (zh) |
AR (1) | AR076556A1 (zh) |
AU (1) | AU2010246724B2 (zh) |
BR (1) | BRPI1013930A2 (zh) |
CA (1) | CA2761383A1 (zh) |
CL (1) | CL2011002814A1 (zh) |
CO (1) | CO6460741A2 (zh) |
CR (1) | CR20110590A (zh) |
DO (1) | DOP2011000351A (zh) |
EA (1) | EA201171381A1 (zh) |
GE (1) | GEP20146006B (zh) |
IL (1) | IL216148A0 (zh) |
MA (1) | MA33351B1 (zh) |
MX (1) | MX2011011885A (zh) |
NZ (1) | NZ596738A (zh) |
SG (1) | SG175968A1 (zh) |
TN (1) | TN2011000557A1 (zh) |
TW (1) | TW201041857A (zh) |
WO (1) | WO2010130260A2 (zh) |
ZA (1) | ZA201108112B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI349666B (en) * | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
MX2009002002A (es) * | 2006-08-23 | 2009-07-22 | Valeant Pharmaceuticals Int | Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potasio. |
CA2694887A1 (en) * | 2007-08-01 | 2009-02-05 | Henriette Husum Bak-Jensen | Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
-
2010
- 2010-05-06 TW TW099114459A patent/TW201041857A/zh unknown
- 2010-05-10 AR ARP100101588A patent/AR076556A1/es unknown
- 2010-05-11 MA MA34435A patent/MA33351B1/fr unknown
- 2010-05-11 CA CA2761383A patent/CA2761383A1/en not_active Abandoned
- 2010-05-11 MX MX2011011885A patent/MX2011011885A/es not_active Application Discontinuation
- 2010-05-11 JP JP2012510116A patent/JP2012526152A/ja active Pending
- 2010-05-11 WO PCT/DK2010/050101 patent/WO2010130260A2/en active Application Filing
- 2010-05-11 CN CN2010800321765A patent/CN102459208A/zh active Pending
- 2010-05-11 KR KR1020117026958A patent/KR20120022934A/ko not_active Application Discontinuation
- 2010-05-11 EP EP10719726A patent/EP2430008A2/en not_active Withdrawn
- 2010-05-11 NZ NZ596738A patent/NZ596738A/xx not_active IP Right Cessation
- 2010-05-11 AU AU2010246724A patent/AU2010246724B2/en not_active Ceased
- 2010-05-11 BR BRPI1013930A patent/BRPI1013930A2/pt not_active IP Right Cessation
- 2010-05-11 SG SG2011082492A patent/SG175968A1/en unknown
- 2010-05-11 GE GEAP201012498A patent/GEP20146006B/en unknown
- 2010-05-11 EA EA201171381A patent/EA201171381A1/ru unknown
-
2011
- 2011-11-03 IL IL216148A patent/IL216148A0/en unknown
- 2011-11-04 TN TNP2011000557A patent/TN2011000557A1/en unknown
- 2011-11-04 ZA ZA2011/08112A patent/ZA201108112B/en unknown
- 2011-11-10 CL CL2011002814A patent/CL2011002814A1/es unknown
- 2011-11-11 CO CO11153611A patent/CO6460741A2/es not_active Application Discontinuation
- 2011-11-11 DO DO2011000351A patent/DOP2011000351A/es unknown
- 2011-11-11 CR CR20110590A patent/CR20110590A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2012526152A (ja) | 2012-10-25 |
AU2010246724B2 (en) | 2013-03-21 |
TN2011000557A1 (en) | 2013-05-24 |
CL2011002814A1 (es) | 2012-04-13 |
IL216148A0 (en) | 2012-01-31 |
AR076556A1 (es) | 2011-06-22 |
SG175968A1 (en) | 2011-12-29 |
WO2010130260A2 (en) | 2010-11-18 |
MX2011011885A (es) | 2011-12-06 |
WO2010130260A9 (en) | 2012-10-18 |
BRPI1013930A2 (pt) | 2019-09-24 |
WO2010130260A3 (en) | 2011-06-16 |
TW201041857A (en) | 2010-12-01 |
DOP2011000351A (es) | 2012-01-31 |
EP2430008A2 (en) | 2012-03-21 |
NZ596738A (en) | 2013-04-26 |
CR20110590A (es) | 2012-02-22 |
GEP20146006B (en) | 2014-01-10 |
CA2761383A1 (en) | 2010-11-18 |
EA201171381A1 (ru) | 2012-05-30 |
CN102459208A (zh) | 2012-05-16 |
CO6460741A2 (es) | 2012-06-15 |
AU2010246724A1 (en) | 2011-12-08 |
KR20120022934A (ko) | 2012-03-12 |
ZA201108112B (en) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI200700160A (es) | Formas cristalinas del hidrocloruro de (r)-8-cloro-1-metil-2,3,4,5-tetrahidro-1h-3-benzazepina | |
TW200736247A (en) | Compounds for the treatment of inflammatory disorders | |
DK2824183T3 (da) | Fremgangsmåde til fremstilling af bispecifikke antistoffer | |
EA200800549A1 (ru) | Региоселективный способ получения бензимидазолтиофенов | |
GT200500296A (es) | Sintesis asimetrica de derivados del dehidrobenzofurano | |
MA32977B1 (fr) | Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol | |
PL380915A1 (pl) | Sposób wytwarzania azotkowego podłoża półprzewodnikowego oraz azotkowe podłoże półprzewodnikowe | |
IT1392456B1 (it) | Processo per la sintesi di di- o oligosaccaridi l-fucosilati e loro nuovi intermedi 2,3,4-tribenzil-fucosil-derivati. | |
BRPI0710199A2 (pt) | Processo para preparação de inibidores de hiv protease | |
DK2082054T3 (da) | Fremgangsmåde til forbedring af udbyttet af celluloseomdannelsesprocesser | |
MY146084A (en) | Benzyl amines, a process for their production and their use as anti-inflammatory agents | |
TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
NO20071254L (no) | Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. | |
EA200870038A1 (ru) | Способ получения аминов | |
BRPI0914400A2 (pt) | "processo para a síntese de um composto" | |
MY148880A (en) | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression | |
FR2950880B1 (fr) | Procede de preparation d'anhydrite pour la fabrication d'un mortier | |
HN2009001437A (es) | Nueva procedimiento de obtencion de la forma cristalina v de la agomelatina | |
MA29092B1 (fr) | Procédé de synthèse de salicylamides n-substitués | |
MA33351B1 (fr) | Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide | |
BRPI0914350A2 (pt) | "processo para a síntese de um composto" | |
MC200131A1 (fr) | Procédé et installation pour la fabrication d'un liant sulfatique à hautes résistances mécaniques précoces, resistant à l'eau et le liant ainsi obtenu | |
ZA201001694B (en) | Process for the manufacture of bridged monobactam intermediates | |
GB0713566D0 (en) | The Synthesis of,N-alkylbis(orciny)phenox AZinones;N-alkyl 3,6-D1(1'3'-Dihydroxy-5'-methylbenzene 6')4,5-Dimethylphenoxazin-2-one-7-oxides | |
FI20051058A0 (fi) | Menetelmä puhtaiden enantiomeerien valmistukseen |